Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.89 USD
-0.65%
Market Closed
Updated:
Apr 25, 2024
Abbott Laboratories
Total Equity
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Total Equity Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$38.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Equity
$25.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$19.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Equity
$6.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$18.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$13.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
See Also
What is Abbott Laboratories's Total Equity?
Total Equity
38.6B
USD
38.6B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Total Equity amounts to 38.6B USD.
What is Abbott Laboratories's Total Equity growth rate?
Total Equity CAGR 10Y
5%
5%
Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Abbott Laboratories have been 5% over the past three years , 5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
